We are live on ! Find out more
BVS icon

Bioventus

53 hedge funds and large institutions have $364M invested in Bioventus in 2021 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 15 increasing their positions, 14 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

67% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 12

50.48% more ownership

Funds ownership: 0%50.48% (+50%)

18% more funds holding

Funds holding: 4553 (+8)

9% more capital invested

Capital invested by funds: $334M → $364M (+$30.3M)

7% more repeat investments, than reductions

Existing positions increased: 15 | Existing positions reduced: 14

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

Holders
53
Holders Change
+8
Holders Change %
+17.78%
% of All Funds
0.92%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
20
Increased
15
Reduced
14
Closed
12
Calls
Puts
Net Calls
Net Calls Change

BVS Hedge Fund Activity: Q2 2021 in Review

53 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Bioventus (BVS) for Q2 2021, worth a combined $364M — up 9.1% from $334M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new BVS positions and 12 closed out — a net gain of 8 holders — while 15 added to existing stakes and 14 trimmed.

The largest buyer was Nuance Investments, opening a new position worth an estimated $11.2M. The largest seller was Avidity Partners Management, exiting entirely with an estimated $19.2M sold.

  • 53 institutional investors held Bioventus (BVS) as of Q2 2021, up from 45 in Q1 2021.
  • Funds reported $364M of Bioventus stock for Q2 2021, up 9.1% quarter-over-quarter.
  • 20 funds opened new Bioventus positions in Q2 2021 and 12 closed out, a net change of +8 holders.
  • The largest Bioventus buyer in Q2 2021 was Nuance Investments, an estimated $11.2M added.
  • The largest Bioventus seller in Q2 2021 was Avidity Partners Management, an estimated $19.2M sold.

Based on aggregated 13F filings for Q2 2021.